Analyst Ratings for Oyster Point Pharma (OYST)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 4 / 10
Percentile Rank: 39%
Rating Score: 4 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/8/2022 | Chardan | Daniil Gatauli | Downgrade | Neutral (Buy) |
13.00 (N/A) |
8.35 (11.17) |
33.77% | Details |
| 11/8/2022 | Piper Sandler | Joseph Catanzaro | Downgrade | Neutral (Overweight) |
11.00 (15.00) |
8.35 (11.17) |
33.77% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


